Global shifts affecting clinical trial supply and sourcing
Emerging geographic dependencies and areas of risk
What the data tells us about how the market is changing
Key trends sponsors should be preparing for
Understanding where reducing cost versus protecting patient safety creates real tension in clinical supply
Exploring trade-offs between speed cost and quality versus operational risk and trial integrity
Debating when cost reduction is justified versus when it creates unacceptable risk
Defining where efficiency gains are possible versus where quality must remain non-negotiable
Clinical supply uncertainty becomes manageable when supply considerations are introduced during protocol design and connected through a structured digital thread spanning planning, RTSM execution, and operational data
Endpoint demonstrates how closing the loop between forecasts and trial actuals enables teams to recognize change earlier, understand its implications faster, and act before it creates patient or study risk
Building strong cross-functional alignment before first patient in
Identifying and addressing operational risks early to avoid costly delays
Creating effective communication between sponsors, vendors and clinical supply teams
Practical lessons and common pitfalls from early-stage biotech programmes
Understanding how demand impacts clinical supply operations
Improving responsiveness during changing enrolment and country expansion
Reducing overproduction, waste and unnecessary shipments
Managing data for real-time supply planning
Sharing practical lessons from global studies
Improving patient adherence through smart packaging and digital reminders
Protecting medicine integrity with real-time monitoring and traceability
Supporting clinical trials through connected packaging solutions
Lessons learned from implementing digital technologies in clinical trials
Exploring the practical benefits of Digital Display Labels for improving clinical trial supply operations
A demonstration of the functionality of DDLs; just-in-time labelling, lot & expiry update, multiple page count
Implementing the operational framework to securely manage remote content and language updates across global clinical trials
Key considerations for implementing DDLs across different IMP formats, including vials, bottles and blisters
Understanding where compliance and operational risks most commonly arise in pharma air freight supply chains,
Managing regulatory challenges, including Good Distribution Practice (GDP), and the role of CEIV Pharma in mitigating risks and ensuring compliance.
Applying practical risk mitigation tools and planning strategies during transportation to avoid disruption and temperature excursions
Posts navigation
